Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality - Wikidata - awgldk - TriplyDB

Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality

Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality

http://www.wikidata.org/entity/Q33959166

about

Plasma butyrylcholinesterase regulates ghrelin to control aggression Choosing wisely - when to mend a broken heart with ECMO?Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.Different sensitivities of rat skeletal muscles and brain to novel anti-cholinesterase agents, alkylammonium derivatives of 6-methyluracil (ADEMS)Reduced serum butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma.An updated role of microRNA-124 in central nervous system disorders: a review.Serum Total Cholinesterase Activity on Admission Is Associated with Disease Severity and Outcome in Patients with Traumatic Brain Injury.Identification and Functional Analysis of MicroRNAs in Mice following Focal Cerebral Ischemia Injury Non-neuronal cholinergic activity is potentiated in myasthenia gravis.Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review.Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load Similar cation channels mediate protection from cerebellar exitotoxicity by exercise and inheritance.Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.Preclinical studies on neurobehavioral and neuromuscular effects of cocaine hydrolase gene therapy in mice.Immunomodulatory effects of nicotine on interleukin 1β activated human astrocytes and the role of cyclooxygenase 2 in the underlying mechanism.Serum Butyrylcholinesterase Activity: A Biomarker for Parkinson's Disease and Related Dementia.Quantum dot labeling of butyrylcholinesterase maintains substrate and inhibitor interactions and cell adherence features.Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders.Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.

P2860

Q28256391-BEB663F7-9EED-4B1C-BEEF-C26731DFDF5C Q33762726-2031060D-02C1-4F47-ABDF-B4CDE695A6DF Q33985983-3741DD99-87FF-47D4-BDA2-69F11616D4E4 Q34103317-A41D14B5-FC42-47BC-A637-E5B3AFD82781 Q35036163-33F0DD66-AA29-4302-83A3-87D6EBACD4EF Q35119140-702529A8-7A60-4A90-B4C8-20D83870181A Q35216136-20C4B605-F5BC-4E53-89B1-39F751C3A7DC Q35619485-B8A8B14D-2A26-4D4E-AD4C-6F90AF283904 Q35626122-264E6961-4D23-470C-852A-3B9FA3F8C690 Q35673243-8AAB9984-755F-4FCB-9880-AD7CE9337E30 Q36247404-693F9390-F6EF-4C69-B2A2-4709FB56E135 Q36274478-BF622492-9B3D-4AE9-B15A-5D7F829AA917 Q36779120-D41BFC23-0A12-40F8-9471-06AE5E888FBA Q37158584-ECEE235F-5A8F-4BCF-BC75-AC0D6F463A97 Q37294815-2E428434-197A-40DF-B17A-79AF65B8AACB Q37633224-F78D7E8C-02E9-4499-9ED7-9F4DFE8C520A Q37697136-ACDB0147-AC35-4AE5-9DBD-4A356B3F103E Q39342494-AD9DE09F-5735-4EE4-BCEE-399007C77401 Q41439506-1A71636A-6C2A-43F2-ADCD-C2090FCA7715 Q41880996-27A22C17-F26F-4427-B939-D1DA761BA5D4 Q41936990-D298592E-6339-40ED-A7CE-886E8395D287 Q47824855-E16B3F77-884E-4ED8-B8FD-664A98E0D22F

P2860

Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality

http://www.wikidata.org/entity/Q33959166

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Serum cholinesterase activitie ...... and predict 12-month mortality

@ast

Serum cholinesterase activitie ...... and predict 12-month mortality

@en

type

label

Serum cholinesterase activitie ...... and predict 12-month mortality

@ast

Serum cholinesterase activitie ...... and predict 12-month mortality

@en

prefLabel

Serum cholinesterase activitie ...... and predict 12-month mortality

@ast

Serum cholinesterase activitie ...... and predict 12-month mortality

@en

P1433

Q33959166-60EF6CF3-ED8B-4292-ABC3-1B8F716E11CF

P1476

Q33959166-DDDC03EB-E553-4C83-A9D0-ACDD8FD92A7A

P2093

Q33959166-0FBFB2C9-B17C-49B1-88BD-50107A7A9EB4

Q33959166-122D2C63-685E-485C-BB91-1E07578EC032

Q33959166-1F648BA5-7D40-4A52-8F1A-23679686FE37

Q33959166-504186FB-B4BE-4732-8815-550B7FB79412

Q33959166-5714B50B-43AB-4903-A757-16E0AFDBE06C

Q33959166-5B68A3EF-2399-4191-BE19-4A5F484E7F61

Q33959166-7FE441A7-8914-48ED-A674-119C14F47FC6

Q33959166-BBF477C7-BC26-4853-BEAF-CB61B40F304B

Q33959166-D380AC3E-0D90-4550-878E-23C08136558B

Q33959166-EE2CD482-AF3D-4376-9CC2-34FE2116A720

P2860

Q33959166-0CB2EB2F-FB1A-488F-8129-2722385A04FE

Q33959166-1715796C-2AAC-4AC7-B48D-69B76D6FB7B5

Q33959166-206C1E82-5D78-4402-A287-41C525ACE1FC

Q33959166-27020390-5347-4DE3-B4CF-AB1FC929D0CB

Q33959166-359D9AD4-36B5-4B2F-A811-102AA2917BF3

Q33959166-4CCB09B1-1D99-4F52-9FA6-5759DD4F5339

Q33959166-5D3B61D8-E914-4BDC-983A-D997707C0911

Q33959166-6448C637-C02A-4BF0-AB18-D7FA272DFD57

Q33959166-6B1D51F1-A3A3-4CF4-8509-8AC359972860

Q33959166-89D060F7-9EF6-46A6-94A6-3545E7FB16FD

P2888

Q33959166-A96F898D-2607-4CCC-BC62-F15142EB1228

P304

Q33959166-E803F9B3-B62B-45F0-9BA8-146960E2CF3E

P31

Q33959166-B6DEF8AF-AB9A-46A1-B23E-4D491C7AC3D8

P356

Q33959166-4A6E31C1-8734-4F38-BD2D-EF46DC257079

P407

Q33959166-47AA8C2B-F6B6-495B-8BF5-11D8D40132DB

P433

Q33959166-AD1F560C-37C8-4C98-B5B7-4138C2DFE20D

P478

Q33959166-44DBA241-D87B-4545-BF3C-62370E5E4DFE

P577

Q33959166-9AD4A8A7-DFC0-43F8-8CE3-36C248DAFA5A

P5875

Q33959166-5D99A7C7-4AB8-4A4C-B49C-75AB33339477

P6179

Q33959166-9696DF71-9A37-499F-B298-3CA38A962B71

P698

Q33959166-B13F9567-EA3F-4B61-B4A6-49AE77DB592A

P932

Q33959166-700453C0-8E64-44AD-935E-A89A9548D107

P356

MOLMED.2010.00015

P1433

Molecular Medicine

P1476

Serum cholinesterase activitie ...... and predict 12-month mortality

@en

P2093

Einor Ben Assayag

http://www.w3.org/2001/XMLSchema#string

Hermona Soreq

http://www.w3.org/2001/XMLSchema#string

Irena Bova

http://www.w3.org/2001/XMLSchema#string

Itzhak Shapira

http://www.w3.org/2001/XMLSchema#string

Keren Ofek

http://www.w3.org/2001/XMLSchema#string

Lilach Soreq

http://www.w3.org/2001/XMLSchema#string

Ludmila Shopin

http://www.w3.org/2001/XMLSchema#string

Natan M Bornstein

http://www.w3.org/2001/XMLSchema#string

Ronan M G Berg

http://www.w3.org/2001/XMLSchema#string

Shani Shenhar-Tsarfaty

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers.

Acute stress facilitates long-lasting changes in cholinergic gene expression.

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites

Myasthenia gravis: myasthenia vs. cholinergic crisis.

Blood biomarkers in the diagnosis of ischemic stroke: a systematic review.

P2888

molmed.2010.00015

P304

278-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2119/MOLMED.2010.00015

http://www.w3.org/2001/XMLSchema#string

P407

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44593597

http://www.w3.org/2001/XMLSchema#string

P6179

1068965257

http://www.w3.org/2001/XMLSchema#string

P698

20464061

http://www.w3.org/2001/XMLSchema#string

P932

2896466

http://www.w3.org/2001/XMLSchema#string